Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2011-12-05 15:58:14
Reporting Period:
Filing Date:
Filing Date Changed:
Accepted Time:
2011-12-05 15:58:14
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352455 Jane Wasman 15 Skyline Drive
Hawthorne NY 10532
Exec Vp, General Counsel & Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-12-01 7,344 $22.92 57,570 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
  2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $22.73 to $23.18 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!